Skip to main content

Table 1 Baseline characteristics (general)

From: Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634]

 

Fluvoxamine N = 17

Placebo N = 16

P-value

Male/Female

4/13

6/10

0.38

PBC/PSC

12/5

10/6

0.57

Age (median)

51

54

0.38

Pruritus (yes/no)

9/8

8/8

0.87

UDCA dose (median, mg/day)

750

900

0.14

Previous depressive disorder (yes/no)

(0/17)

(1/15)

0.30

Weight (median, kg)

67

71

0.95

Length (median, cm)

173

171

0.67

Body Mass Index (median)

24.2

24.6

0.61

Haemoglobin (mmol/l, median)

8.3

8.8

0.21

Bilirubin (μmol/l, median)

13

11.5

0.83

Alkaline Phosphatase (U/l, median)

137

192

0.36

ALT (U/l, median)

42

43

0.55

Albumin (U/l, median)

42

41.5

0.81

  1. Laboratory reference values: haemoglobin 7.5–9.5 mmol/l, bilirubin 0–16 μmol/l, alkaline phosphatase 0–119 U/l, ALT 0–30 U/l, albumin 35–50 g/l.